Sidney A. Spector
Corporate Officer/Principal presso University of Arizona College of Medicine
Posizioni attive di Sidney A. Spector
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Arizona College of Medicine | Corporate Officer/Principal | - | - |
Proxenia Venture Partners LLC
 Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners LLC (Proxenia Venture Partners) is a venture capital firm founded in 2016 by Menghis Bairu. The firm is headquartered in wilmington, Delaware. | Corporate Officer/Principal | - | - |
Storia della carriera di Sidney A. Spector
Precedenti posizioni note di Sidney A. Spector
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 08/11/2021 | 01/03/2023 |
AveXis EU Ltd.
 AveXis EU Ltd. BiotechnologyHealth Technology Part of Novartis AG, AveXis EU Ltd. develops gene therapy products. The company is based in Dublin, Ireland. | Investitore di Private Equity | 01/03/2018 | 01/06/2019 |
| AVEXIS INC | Corporate Officer/Principal | - | - |
Formazione di Sidney A. Spector
| University of California, Los Angeles | Doctorate Degree |
| Sackler School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Israele | 2 |
| Irlanda | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 4 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
AveXis EU Ltd.
AveXis EU Ltd. BiotechnologyHealth Technology Part of Novartis AG, AveXis EU Ltd. develops gene therapy products. The company is based in Dublin, Ireland. | Health Technology |
Proxenia Venture Partners LLC
Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners LLC (Proxenia Venture Partners) is a venture capital firm founded in 2016 by Menghis Bairu. The firm is headquartered in wilmington, Delaware. | Finance |
- Borsa valori
- Insiders
- Sidney A. Spector
- Esperienza
